Pharmacovigilance Coordinator (FV) for the Clinical Research Unit in Clinical Trials

 Reference: 23-150_SS_PH

About the unit

Clinical Research and Clinical Trial Unit (UICEC) is an IDIBELL platform that gives support to the clinical research groups to conduct clinical studies without any commercial interest. UICEC activities respond to the responsibilities of researches as promoter of clinical trials (CT).

UICEC IDIBELL is part of the SCREN, a ISCIII Clinical Research Support Platform (PT20/00008).

About the role

• Coordination of the Pharmacovigilance
• Preparation of the Pharmacovigilance Plan for the CT carried out at the UICEC and carry out the corresponding follow-up
• Registration, evaluation and management of serious advers events
• Preparation of the clinical trial Annual Safety Report
• Review and update of the Reference Safety Information for the CT investigation medicinal products. Identification and management of safety problems of CT

Job requirements

Professional experience

Education and training

• Specialisation in Clinical Pharmacology (MIR)
• Certification for the notification of adverts events in Eudravigilance
• National Health System knowledge/experience
• High English level

What do we offer

• No. of positions: 1
• Start date: As soon as possible
• Contract duration: Permanent, linked to projects
• Estimated annual gross salary: it is commensurate with qualifications and consistent with our pay ranges.
• You will be part of a multicultural team. We have a fun loving and friendly international work environment.
• Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
• Possibility to work some days in remote - Teleworking
• 26 working days of holiday per year
• System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
• Paid leave package
• Benefits of constant training are offered
• We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Selection process

• Pre-selection: The pre-selection process will consist on an eligibility check based on qualifications and expertise reflected on the candidate's CV.
  
• Interview: Best positioned, pre-selected candidates may be called to arrange an interview. Candidates will be interviewed by the hiring manager and an ad hoc selection panel.
  
• Formal offer letter: Once identified, the Talent Unit will send a job offer to the successful candidate indicating start date, salary, working conditions, and any additional relevant details.
  
  
  
  

Deadline: Please submit your application by 11/09/2023

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.


Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code). 

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

This contract is financed by the Instituto de Salut Carlos III, with file code PT20/00008, by virtue of a Resolution of the Directorate of the Instituto de Salut Carlos III, O.A., M.P. of December 11, 2020, by which subsidies are granted for the Units of the ISCIII Platforms to support R+D+I in Biomedicine and Health Sciences of the Strategic Action in Health 2017-2020 (Co-financed by the European Regional Development Fund. FEDER, a way of making Europe).